Several systems from the hyperactive 2020 hurricane season, including many of the land-falling storms along the Gulf Coast, developed in a similar way, stemming from a breeding ground created by an ...

Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.

The Central American Gyre is a broad, weak low-pressure system that can trigger the formation of tropical storms and hurricanes during hurricane season. The National Hurricane Center is currently ...

Read full article: National Hurricane Center highlights area of interest in the Caribbean. Here’s the latest We have a new possible threat for tropical activity close to home in the western Caribbean.

Acquisition will create a U.S.- and China-based fully integrated biopharmaceutical company with revenue-producing commercial ...

Gyre Therapeutics' stock is volatile - I'm upholding my "Hold" rating due to uncertain long-term prospects and potential dilution from future funding needs. The company's products include Etuary, and ...

Add Yahoo as a preferred source to see more of our stories on Google. It's not quite hurricane season yet, but AccuWeather is already sounding the alarm bells as it warns we could be seeing the signs ...

It's not quite hurricane season yet, but AccuWeather is already sounding the alarm bells as it warns we could be seeing the signs of a tropical storm that could spin up later this month. The Central ...